MedPath

Observational study of the treatment for low risk neuroblastomas with decision of surgical indications based on IDRF (Image Defined Risk Factors)

Not Applicable
Recruiting
Conditions
neuroblastoma
Registration Number
JPRN-UMIN000004355
Lead Sponsor
Japan Neuroblastoma Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Active double cancer, pregnant or possiblly pregnant women and those during breast feeding, patients with psychologic disease or symptoms who have difficulty in receiving protocol treatment, patients with disease that may interfere with the protocol treatment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3-year progression free survival rate 3-year overall survival rate The incidence of surgical complication The incidence of adverse events
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath